13F Holdings
中文EN

STAA STAAR SURGICAL CO

Ophthalmic Goods · Nasdaq · SEC CIK 718937 · Fiscal year ends 01/02

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY42.4%
TTM net income YoY100.5%
TTM EPS YoY100.5%
Revenue 3-yr CAGR1.9%
Net income 3-yr CAGR-69.9%

Margins

Gross margin73.6%
Operating margin0.2%
Net margin0.2%
FCF margin5.4%
EBITDA margin2.9%

Returns

ROE0.1%
ROA0.1%
ROIC (approx.)0.2%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets22.5%
Debt / equity0.00x
Current ratio4.68x
Interest coverage—

Cash quality & payout

Operating cash flow / net income40.37x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252026-01-02FY20242024-12-27FY20232023-12-29FY20222022-12-30FY20212021-12-31
Income statement
Revenue$239.44M$313.90M$322.42M$239.44M$230.47M
Cost of revenue$57.02M$74.32M$69.76M$61.01M$51.84M
Gross profit$182.42M$239.58M$252.65M$223.38M$178.64M
R&D expense$40.05M$45.32M$40.48M$35.98M$33.86M
SG&A expense$274.13M$252.19M$224.55M$179.58M$145.30M
Operating income-$91.71M-$12.61M$28.10M$43.80M$33.34M
Pretax income-$82.26M-$9.05M$33.70M$45.55M$31.30M
Income tax-$1.81M$11.16M$12.35M$5.89M$3.79M
Net income-$80.45M-$20.21M$21.35M$39.66M$27.51M
EBITDA-$83.39M-$5.72M$33.21M$48.28M$36.95M
EPS (basic)-1.62-0.410.440.830.58
EPS (diluted)-1.62-0.410.430.800.56
Weighted avg. shares (diluted)49.57M49.12M49.43M49.38M49.46M
Balance sheet
Cash & equivalents$153.15M$144.16M$183.04M$86.48M$199.71M
Short-term investments$34.39M$86.33M$37.69M$125.16M—
Receivables$50.06M$77.90M$94.70M$62.45M$43.53M
Inventory$58.42M$44.58M$38.64M$25.84M$18.43M
Current assets$311.55M$367.94M$365.27M$311.72M$271.41M
PP&E, net$73.32M$84.89M$66.83M$50.92M$35.91M
Goodwill$1.79M$1.79M$1.79M$1.79M$1.79M
Intangibles———$173,000$218,000
Total assets$451.68M$509.52M$488.69M$418.82M$345.78M
Current liabilities$68.50M$70.31M$65.04M$51.72M$48.80M
Total liabilities$107.49M$112.19M$102.74M$82.71M$87.22M
Shareholders' equity$344.18M$397.33M$385.95M$336.11M$261.57M
Shares outstanding49.40M49.29M48.84M48.21M47.72M
Cash flow statement
Operating cash flow-$34.23M$15.72M$14.59M$35.72M$43.96M
Capital expenditure$5.82M$23.39M$18.19M$18.11M$13.64M
Free cash flow-$40.05M-$7.67M-$3.59M$17.61M$30.32M
Investing cash flow$46.34M-$59.22M$74.35M-$156.38M-$13.64M
Financing cash flow-$4.55M$5.72M$7.42M$8.30M$17.79M
Depreciation & amortization$8.32M$6.89M$5.11M$4.48M$3.61M
Stock-based compensation$30.59M$27.21M$23.52M$20.37M$14.61M
Share buybacks$6.46M————

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.